METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Clinical trials for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gentler chemo combo offers hope for elderly lung cancer patients
Disease control Recruiting nowThis study is for people aged 70 and older with advanced non-small cell lung cancer who are too frail for standard chemotherapy. It compares a lower-dose chemo plus an immunotherapy drug (cemiplimab) against immunotherapy alone. The goal is to find a treatment that works well but…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for Hard-to-Treat lung cancer: targeted drug combo shows promise
Disease control Recruiting nowThis phase 2 trial is testing a combination of the targeted drug amivantamab plus chemotherapy (pemetrexed or gemcitabine) in 33 people with advanced non-small cell lung cancer that has a specific EGFR exon20 insertion mutation. Participants have not had prior treatment and are n…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Fondazione Ricerca Traslazionale • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Simple blood test may predict immunotherapy success in lung cancer
Knowledge-focused Recruiting nowThis study is looking at whether large granular lymphocytes (LGLs), a type of immune cell, can predict how well patients with advanced non-small cell lung cancer respond to the immunotherapy drug nivolumab. Researchers will measure LGL levels in 50 patients before and during trea…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Sponsor: Necmettin Erbakan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC